analyst
NG
NASDAQ · NGNE
Neurogene Inc.
Healthcare · Biotechnology
$36.58
Down-$0.57 (-1.54%)
Updated Aug 31, 2026, 5:04 PM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 329.3M
- P/E ratio
- -5.29
- Dividend yield
- 0.00%
- 52-week range
- $18.23 – $43.66
- Volume
- 132.8K
- Avg. volume
- 231.35K
Price performance
NGNE price history
1M range · 20 trading sessions · Daily adjusted prices
NGNE closed at $36.58 after 20 trading sessions, up 11.29% for the selected period.
- Last close
- $36.58
- Period change
- +11.29%
- Period low
- $32.87
- Period high
- $40.84
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $37.68 | $38.56 | $36.315 | $36.58 | 132.8K |
| Aug 27, 2026 | $38.50 | $39.81 | $37.39 | $37.86 | 149.92K |
| Aug 26, 2026 | $40.74 | $41.77 | $38.27 | $38.41 | 180.17K |
| Aug 25, 2026 | $40.09 | $42.01 | $39.125 | $40.84 | 504.34K |
| Aug 24, 2026 | $38.64 | $40.82 | $37.50 | $39.64 | 439.1K |
| Aug 21, 2026 | $38.41 | $39.44 | $37.535 | $38.63 | 346.58K |
| Aug 20, 2026 | $38.55 | $38.60 | $36.78 | $37.99 | 124.69K |
| Aug 19, 2026 | $36.85 | $40.155 | $35.90 | $39.43 | 383.1K |
| Aug 18, 2026 | $36.35 | $36.99 | $35.21 | $35.67 | 88.44K |
| Aug 17, 2026 | $36.14 | $37.18 | $35.42 | $36.68 | 91.13K |
| Aug 14, 2026 | $35.44 | $36.40 | $34.465 | $36.14 | 115.86K |
| Aug 13, 2026 | $37.24 | $38.00 | $35.47 | $35.63 | 140.29K |
| Aug 12, 2026 | $36.59 | $37.275 | $35.715 | $36.98 | 342.64K |
| Aug 11, 2026 | $36.19 | $36.27 | $30.57 | $35.80 | 352.61K |
| Aug 10, 2026 | $35.68 | $36.89 | $35.19 | $36.55 | 214.31K |
| Aug 7, 2026 | $36.02 | $36.68 | $34.60 | $35.69 | 103.22K |
| Aug 6, 2026 | $36.01 | $36.50 | $35.375 | $35.60 | 94.29K |
| Aug 5, 2026 | $34.66 | $36.30 | $34.36 | $35.98 | 167.58K |
| Aug 4, 2026 | $33.01 | $34.6199 | $33.01 | $34.41 | 142.21K |
| Aug 3, 2026 | $33.52 | $33.69 | $31.86 | $32.87 | 155.55K |
Latest NGNE news
The latest Smart Investors Daily articles mentioning NGNE.
Stock researchResearch & News · SEC Filings
Loading stock research…